NEW YORK (GenomeWeb News) – Glioblastoma tumors essentially hide mutant EGFR in response to therapies targeting those mutations, a new study appearing in Science reported today. Further, after drug treatment is stopped, those mutations reappear.
Registering provides access to this and other free content.
Already have an account?Login Now.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.